About Resistell
Resistell is a company based in Basel (Switzerland) founded in 2017. Resistell has raised $13.44 million across 6 funding rounds from investors including TRUMPF, Pfizer and Zurcher Kantonalbank. Resistell operates in a competitive market with competitors including OpGen, NOWDiagnostics, Avails Medical, HandyLab and DNA Electronics, among others.
- Headquarter Basel, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Resistell Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.44 M (USD)
in 6 rounds
-
Latest Funding Round
$9.13 M (USD), Series B
Dec 19, 2022
-
Investors
TRUMPF
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Resistell
Resistell has successfully raised a total of $13.44M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $9.13 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Resistell
Resistell has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include TRUMPF, Pfizer and Zurcher Kantonalbank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided to deep-tech startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for Resistell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resistell
Investment portfolio details for Resistell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Resistell
Detailed financials for Resistell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resistell Comparisons
Peer comparison for Resistell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Resistell
Resistell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, NOWDiagnostics, Avails Medical, HandyLab and DNA Electronics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
|
|
| Locked | Locked | Locked |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays and automation platforms are developed.
|
|
| Locked | Locked | Locked |
Semi-conductor-based NGS diagnostics for infectious diseases are offered.
|
|
| Locked | Locked | Locked |
Instruments and assays for molecular pathogen detection are developed.
|
Detailed competitors of Resistell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resistell
Complete news archive for Resistell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resistell
Resistell was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Resistell is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Resistell is a funded company, having raised a total of $13.44M across 6 funding rounds to date.
Resistell was founded in 2017 in Basel, Switzerland, and operates within the diagnostics sector of healthcare. Antibiotic susceptibility testing is offered through a culture-based antibiogram, with diagnosis enabled by the detection of movement from living bacterial cells. This approach supports the identification of suitable antibiotics and required concentrations for patient treatment, facilitating informed clinical decisions in infectious disease management.
Resistell's top competitors include Avails Medical, OpGen and Verax Biomedical.
Resistell has 10 investors. Key investors include TRUMPF, Pfizer, Zurcher Kantonalbank, European Union, and HEMEX.